212 related articles for article (PubMed ID: 31124321)
1. Levetiracetam Pregnancy Registry: Final results and a review of the impact of registry methodology and definitions on the prevalence of major congenital malformations.
Scheuerle AE; Holmes LB; Albano JD; Badalamenti V; Battino D; Covington D; Harden C; Miller D; Montouris GD; Pantaleoni C; Thorp J; Tofighy A; Tomson T; Golembesky AK
Birth Defects Res; 2019 Aug; 111(13):872-887. PubMed ID: 31124321
[TBL] [Abstract][Full Text] [Related]
2. Preliminary results on pregnancy outcomes in women using lamotrigine.
Tennis P; Eldridge RR;
Epilepsia; 2002 Oct; 43(10):1161-7. PubMed ID: 12366730
[TBL] [Abstract][Full Text] [Related]
3. Antiepileptic drugs and intrauterine death: A prospective observational study from EURAP.
Tomson T; Battino D; Bonizzoni E; Craig JJ; Lindhout D; Perucca E; Sabers A; Thomas SV; Vajda F;
Neurology; 2015 Aug; 85(7):580-8. PubMed ID: 26187231
[TBL] [Abstract][Full Text] [Related]
4. Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry.
Tomson T; Battino D; Bonizzoni E; Craig J; Lindhout D; Perucca E; Sabers A; Thomas SV; Vajda F;
Lancet Neurol; 2018 Jun; 17(6):530-538. PubMed ID: 29680205
[TBL] [Abstract][Full Text] [Related]
5. Fetal safety of levetiracetam use during pregnancy.
Koc G; Keskin Guler S; Karadas O; Yoldas T; Gokcil Z
Acta Neurol Belg; 2018 Sep; 118(3):503-508. PubMed ID: 30056483
[TBL] [Abstract][Full Text] [Related]
6. Comparing the General Practice Research Database and the UK Epilepsy and Pregnancy Register as tools for postmarketing teratogen surveillance: anticonvulsants and the risk of major congenital malformations.
Charlton RA; Weil JG; Cunnington MC; Ray S; de Vries CS
Drug Saf; 2011 Feb; 34(2):157-71. PubMed ID: 21247222
[TBL] [Abstract][Full Text] [Related]
7. Declining malformation rates with changed antiepileptic drug prescribing: An observational study.
Tomson T; Battino D; Bonizzoni E; Craig J; Lindhout D; Perucca E; Sabers A; Thomas SV; Vajda F;
Neurology; 2019 Aug; 93(9):e831-e840. PubMed ID: 31391249
[TBL] [Abstract][Full Text] [Related]
8. Malformation risk of antiepileptic drug exposure during pregnancy in women with epilepsy: Results from a pregnancy registry in South India.
Thomas SV; Jose M; Divakaran S; Sankara Sarma P
Epilepsia; 2017 Feb; 58(2):274-281. PubMed ID: 28084641
[TBL] [Abstract][Full Text] [Related]
9. Levetiracetam in pregnancy: results from the UK and Ireland epilepsy and pregnancy registers.
Mawhinney E; Craig J; Morrow J; Russell A; Smithson WH; Parsons L; Morrison PJ; Liggan B; Irwin B; Delanty N; Hunt SJ
Neurology; 2013 Jan; 80(4):400-5. PubMed ID: 23303847
[TBL] [Abstract][Full Text] [Related]
10. Risk of Major Congenital Malformations and Exposure to Antiseizure Medication Monotherapy.
Battino D; Tomson T; Bonizzoni E; Craig J; Perucca E; Sabers A; Thomas S; Alvestad S; Perucca P; Vajda F;
JAMA Neurol; 2024 May; 81(5):481-489. PubMed ID: 38497990
[TBL] [Abstract][Full Text] [Related]
11. Final results from 18 years of the International Lamotrigine Pregnancy Registry.
Cunnington MC; Weil JG; Messenheimer JA; Ferber S; Yerby M; Tennis P
Neurology; 2011 May; 76(21):1817-23. PubMed ID: 21606453
[TBL] [Abstract][Full Text] [Related]
12. Effects of antiepileptic drugs polytherapy on pregnancy outcomes in women with epilepsy: An observation study in northwest China.
Shi X; Wang Y; Zhang Y; Song C; Jiang Y; Zhao J; Xia L; Ma L; Jiang W
Epilepsy Behav; 2022 Oct; 135():108904. PubMed ID: 36095876
[TBL] [Abstract][Full Text] [Related]
13. Levetiracetam in pregnancy: preliminary experience from the UK Epilepsy and Pregnancy Register.
Hunt S; Craig J; Russell A; Guthrie E; Parsons L; Robertson I; Waddell R; Irwin B; Morrison PJ; Morrow J
Neurology; 2006 Nov; 67(10):1876-9. PubMed ID: 17130430
[TBL] [Abstract][Full Text] [Related]
14. Valproate usage in pregnancy: An audit from the Kerala Registry of Epilepsy and Pregnancy.
Seshachala BB; Jose M; Lathikakumari AM; Murali S; Kumar AS; Thomas SV
Epilepsia; 2021 May; 62(5):1141-1147. PubMed ID: 33782943
[TBL] [Abstract][Full Text] [Related]
15. Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry.
Tomson T; Battino D; Bonizzoni E; Craig J; Lindhout D; Sabers A; Perucca E; Vajda F;
Lancet Neurol; 2011 Jul; 10(7):609-17. PubMed ID: 21652013
[TBL] [Abstract][Full Text] [Related]
16. Malformation risk of new anti-epileptic drugs in women with epilepsy; observational data from the Kerala registry of epilepsy and pregnancy (KREP).
Thomas SV; Jeemon P; Pillai R; Jose M; Lalithakumari AM; Murali S; Sanalkumar A; Salini RA; Pavithran V
Seizure; 2021 Dec; 93():127-132. PubMed ID: 34740142
[TBL] [Abstract][Full Text] [Related]
17. Pregnancy, delivery, and outcome for the child in maternal epilepsy.
Veiby G; Daltveit AK; Engelsen BA; Gilhus NE
Epilepsia; 2009 Sep; 50(9):2130-9. PubMed ID: 19490036
[TBL] [Abstract][Full Text] [Related]
18. Dose-dependent teratogenicity of valproate in mono- and polytherapy: an observational study.
Tomson T; Battino D; Bonizzoni E; Craig J; Lindhout D; Perucca E; Sabers A; Thomas SV; Vajda F;
Neurology; 2015 Sep; 85(10):866-72. PubMed ID: 26085607
[TBL] [Abstract][Full Text] [Related]
19. Antiepileptic drug use during pregnancy: perinatal outcomes.
Kulaga S; Sheehy O; Zargarzadeh AH; Moussally K; Bérard A
Seizure; 2011 Nov; 20(9):667-72. PubMed ID: 21763158
[TBL] [Abstract][Full Text] [Related]
20. Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register.
Morrow J; Russell A; Guthrie E; Parsons L; Robertson I; Waddell R; Irwin B; McGivern RC; Morrison PJ; Craig J
J Neurol Neurosurg Psychiatry; 2006 Feb; 77(2):193-8. PubMed ID: 16157661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
